Thromb Haemost 1973; 30(01): 178-190
DOI: 10.1055/s-0038-1649115
Original Article
Schattauer GmbH

Systemic Effects of ADP-induced Platelet Aggregation and Their Modification by Aspirin and by Pyridinolcarbamate

Itsuro Kobayashi*
1   Section of Laboratory Hematology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, 55901, U.S.A.
,
Paul Didisheim
1   Section of Laboratory Hematology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, 55901, U.S.A.
› Author Affiliations
Further Information

Publication History

Received for publication 28 February 1973

Accepted for publication 22 May 1973

Publication Date:
24 July 2018 (online)

Summary

ADP, AMP, or ATP was injected rapidly intravenously in rats. ADP injection resulted in the f olio wing transient changes: a drop in platelet count, a rise in central venous pressure, a fall in carotid arterial PO2, bradycardia, arrhythmia, flutter-fibrillation, and arterial hypotension. AMP and ATP produced some of these same effects; but except for hypotension, their frequency and severity Avere much less than those following ADP.

Prior intravenous administration of acetylsalicylic acid or pyridinolcarbamate, two inhibitors of the second wave of ADP-induced platelet aggregation in vitro, significantly reduced the frequency and severity of all the above ADP-induced changes except hypotension. These observations suggest that many of the changes (except hypotension) observed to follow ADP injection are produced by platelet aggregates which lodge transiently in various microcirculatory beds then rapidly disaggregate and recirculate.

* Present address: Institute for Cardiovascular Diseases, Tokyo Ika-Shika National University Medical School, Tokyo.


 
  • References

  • 1 Baumgartner H. R, and Haudenschild C. 1972 Adhesion of platelets to subendo thelium. In: Weiss H. J. (Ed.) Platelets and their Role in Hemostasis. Annals of New York Academy of Sciences, 201, 22.
  • 2 Born G. V. R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (London) 194: 927.
  • 3 Born G. V. R, and Cross M. J. 1963; Effect of adenosine diphosphate on the concentration of the platelets in circulating blood. Nature (London) 197: 974.
  • 4 Bounameaux Y. 1959; Accolement des plaquettes aux fibres sousendotheliales. Comptes Rendus des Seances de la Société de Biologie et de ses Filiales 153: 865.
  • 5 Brashear R. E, Mandelbaum I, and Ross J. C. 1970; Selected cardiovascular effects of adenosine diphosphate. American Heart Journal 80: 63.
  • 6 Danese C. A, Voleti Ch. D, and Weiss H. J. 1971; Protection by aspirin against experimentally induced arterial thrombosis in dogs. Thrombosis et Diathesis Haemorrhagica 25: 288.
  • 7 Didisheim P. 1968; Inhibition by dipyridamole of arterial thrombosis in rats. Thrombosis et Diathesis Haemorrhagica 20: 257.
  • 8 Didisheim P. 1972. Animal models useful in the study of thrombosis and antithrombotic agents. In: Spaet T. H. (ed.) Progress in Hemostasis and Thrombosis. Grune and Stratton; New York: 165.
  • 9 Didisheim P, Pavlovskiy M, and Kobayashi I. 1972 Factors affecting hemostatic plug formation in an extracorporeal model. In: Weiss H.J. (ed.) Platelets and their Role in Hemostasis. Annals of New York Academy of Sciences, 201, 307.
  • 10 Didisheim P, and Kobayashi I. (in press): Effect of pyridinolcarbamate on platelet aggregation in vitro and ADP-induced changes in vivo. In: Shimamoto T, Numano F, and Addison G. M. (eds.) Proceedings II International Symposium on Ather o genesis, Thrombogenesis, and Pyridinolcarbamate Treatment. Excerpta Medica Foundation; Amsterdam:
  • 11 Didisheim P, Sturm R. E, and Owen Jr. C. A. 1971 Experiments on thrombosis and its prevention. In: Losito R, and Longprè B. (eds.) Current Concepts of Coagulation and Hemostasis. Supplement to Thrombosis et Diathesis Haemorrhagica, 46, 177.
  • 12 Evans G, Packham M. A, Nishizawa E. E, Mustard J. F, and Murphy E. A. 1968; The effect of acetylsalicylic acid on platelet function. Journal of Experimental Medicine 128: 877.
  • 13 Gaarder A, Johnsen J, Laland S, Hellem A, and Owren P. A. 1961; Adenosine diphosphate in red cells as a factor on the adhesiveness of human blood platelets. Nature (London) 192: 531.
  • 14 Holmsen H. 1972 Ethanol-insoluble adenine nucleotides in platelets and their possible role in platelet function. In: Weiss H. J. (ed.) Platelets and their Role in Hemostasis. Annals of New York Academy of Sciences, 201, 109.
  • 15 Hovig T. 1963; Release of a platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 264.
  • 16 Jorgensen L, Rowsell H. C, Hovig T, Glynn M. F, and Mustard J. F. 1967; Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Laboratory Investigation 17: 616.
  • 17 Kobayashi I, and Didisheim P. 1973 Collagen-induced release of adenine nucleotides from platelets in vivo. Federation Proceedings, 32, 220 Abs.
  • 18 Kobayashi I, Herther K. K, Grabowski E. F, and Didisheim P. 1973 Intravenous collagen-induced release of ADP and ATP in normal or thrombocytopenic rats. Program, 4th Congress, International Society on Thrombosis and Haemostasis, Vienna (abstract).
  • 19 Kricheff I. I, Zucker M. B, Tschopp T. B, and Kolodjiez A. 1973; Inhibition of thrombosis on vascular catheters in cats. Diagnostic Radiology 106: 49.
  • 20 Mackenzie R. D, Henderson J. G, and Steinbach J. M. 1971; The evaluation of a method for adenosine diphosphate induced platelet aggregation in the guinea pig. Thrombosis et Diathesis Haemorrhagica 25: 30.
  • 21 Mustard J. F, Rowsell H. C, Lots F, Hegardt B, and Murphy E. A. 1966; The effect of adenine nucleotides on thrombus formation, platelet count, and blood coagulation. Experimental and Molecular Pathology 5: 43.
  • 22 Nordöy A, and Chandler A. B. 1964; Platelet thrombosis induced by adenosine diphosphate in the rat. Scandinavian Journal of Haematology 1: 16.
  • 23 O’Brien J. R. 1962; Platelet aggregation. Part II. Some results from a new method of study. Journal of Clinical Pathology 15: 452.
  • 24 O’Brien J. R. 1968; Effects of salicylates on human platelets. Lancet 1: 779.
  • 25 Oda M, Tsuchiya T, Shishido T, Kamisaka Y, and Yoshimatsu H. 1970 Effect of pyridi-nolcarbamate on the thrombogenesis following vascular damage. Program of Sixth European Conference on Microcirculation, Aalborg. p. 387.
  • 26 Peter A, Regan T. J, Jesrani M. U, Lahiri K, and Moschos C.B. 1971; Modifying effects of aspirin on experimental coronary thrombosis. Clinical Research 19: 333.
  • 27 Reeves J. T, Jokl P, Merida J, and Leathers J. E. 1967; Pulmonary vascular obstruction following administration of high-energy nucleotides. Journal of Applied Physiology 22: 475.
  • 28 Sano T, and Yokoyama M. 1971; Effect of pyridinolcarbamate on platelet aggregation. American Journal of Medical Science 262: 205.
  • 29 Shimamoto T, Maezawa M, Yamasaki H, Atsumi T, Fujita T, Ishioka T, and Sunaga T. 1966; Pyridinolcarbamate, a bradykinin antagonist in veins. American Heart Journal 71: 297.
  • 30 Shimamoto T, and Numano F. 1969 Atherogenesis. Proceedings of the First International Symposium on Atherogenesis, Thrombogenesis and Pyridinolcarbamate Treatment. Excerpta Medica Foundation, Amsterdam.
  • 31 Spaet T. H, and Stemerman M. B. 1972 Platelet adhesion. In: Weiss H. J. (ed.) Platelets and their Pole in Hemostasis. Annals of New York Academy of Sciences, 201, 13.
  • 32 Swedenborg J, Taylor G, and Olsson P. 1971; Hemodynamic changes of adenosine diphosphate, adenosine triphosphate, and thrombin in relation to their platelet-aggregation activity. Scandinavian Journal of Clinical and Laboratory Investigation 5: 27.
  • 33 Urthaler F, and James T. N. 1972; Effect of adenosine and ATP on AV conduction and on AV junctional rhythm. Journal of Laboratory and Clinical Medicine 79: 96.
  • 34 Weiss H. J, Aledort L. M, and Kochwa S. 1968; The effect of salicylates on the hemostatic properties of platelets in man. Journal of Clinical Investigation 47: 2169.
  • 35 Yamazaki H, Kobayashi I, and Shimamoto T. 1970; a Enhancement of ADP induced platelet aggregation by exercise test in coronary patients and its prevention by pyridinolcarbamate. Thrombosis et Diathesis Haemorrhagica 24: 438.
  • 36 Yamazaki H, Sano T, Odakura T, Takeuchi I, and Shimamoto T. 1970; b Electrocardiographic and hematological changes by exercise test in coronary patients and pyridinolcarbamate pretreatment. A double-blind crossover trail. American Heart Journal 79: 640.
  • 37 Zucker M. B, and Peterson J. 1968; Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetyl-salicylic acid ingestion. Proceedings of the Society for Experimental Biology and Medicine 127: 547.
  • 38 Zucker M. B, and Peterson J. 1970; Effect of acetylsalicylic acid, other nonsteroidal antiinflammatory agents, and dipyridamole on human blood platelets. Journal of Laboratory and Clinical Medicine 76: 66.